Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients

Giuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, Ilaria Ferrari, Alessia Gravina, Roberto Mereu, Ilaria Palumbo, Elena Fogari, Angela D'Angelo, Arrigo F G Cicero
  • Hypertension Research, May 2010, Springer Science + Business Media
  • DOI: 10.1038/hr.2010.85

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1038/hr.2010.85

The following have contributed to this page: Dr Arrigo FG CICERO

In partnership with: